Outreach Core

外展核心

• 批准号: 10328134
• 负责人: YU-MEI M SCHOENBERGER
• 金额: $ 7.43万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-23 至 2026-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10328134
• 关键词: Address; Advanced Malignant Neoplasm; African American; Alabama; Attitude; Awareness; Behavior; Belief; Biomedical Research; Cancer Patient; Catchment Area; Clinical; Clinical Research; Clinical Trials; Communities; Community Health; Comprehensive Cancer Center; Disease; Early Diagnosis; Education; Environment; Evaluation; Genetic; Genomics; Goals; Individual; Institution; Joints; Knowledge; Latinx; Logic; Logistics; Malignant Neoplasms; Medicine; Minority Participation; Modeling; Morehouse School of Medicine; National Cancer Institute; Outcome; Outcome Measure; Participant; Patients; Population; Population Heterogeneity; Prevention; Privacy; Research; Research Project Grants; Resources; Rural Community; Safety; Scientific Advances and Accomplishments; Services; Standardization; Surveys; Tablets; Technology; Therapeutic Clinical Trial; Training; Trust; United States National Institutes of Health; Universities; Urban Community; anticancer research; base; cancer clinical trial; cancer genomics; cancer health disparity; cancer prevention; cancer risk; cancer therapy; clinical trial enrollment; design; education resources; evidence base; health disparity populations; health equity; interest; outreach; precision oncology; preference; programs; recruit; research study; theories

PROJECT SUMMARY: OUTREACH (This core is identical to all three partnering institutions) The overall goal of the Outreach Core is to implement and evaluate an evidence-based, theory-informed, multi- level, clinical trial and cancer genomics education program (CTC-GEP) that addresses the determinants for African American (AA) and Latinx participation in clinical trials and cancer genomics studies. The CTC-GEP is informed by the Increasing Minority Participation in Clinical Trials (IMPaCT) program, an efficacious clinical trials navigator program implemented at the University of Alabama at Birmingham O’Neal Comprehensive Cancer Center. We will build on the findings of this program and extend application of the patient navigation model to participation in clinical trials and genomic cancer research. A cadre of lay community navigator professionals will be trained and serve as clinical trials navigators (CCN) to deliver two unique types of toolkits comprised of evidence-based educational resources on research participation (low-tech) and culturally tailored educational and multiple media content via mobile tablet technology (high-tech). The CCNs will deliver these toolkits and provide logistical support to participants interested in participating in cancer research in rural and urban community health and academic research centers within the Partnership catchment areas. The CTC-GEP will also address AA and Latinx beliefs, values, attitudes, concerns, and preferences related to participation in research, such as privacy, trust, and safety. An evaluation plan based on a logic model will be applied throughout the project. Outcome measures will be assessed through pre- and post- surveys. The outcomes of the CTC- GEP include a) intentions to participate in research, b) awareness and knowledge about research, and c) genomic research and clinical trial enrollment. Additionally, having a Joint Clinical and Biomedical Research Advisory Roundtable (JCAR) guided, clinical community navigation and education program will lead to increased awareness, opportunity and participation in genomic research and clinical trials among a diverse population of AAs and Latinx. The rationale for this Core, intended to facilitate research and not conduct research, is to identify effective strategies to facilitate research participation among AA and Latinx populations. Thus, the activities outlined in this proposal are congruent with the strategies in the Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) RFA listed for the Outreach Core.

项目摘要：外展（此核心与所有三个合作机构相同） 外展核心的总体目标是实施和评估循证，理论知觉的，多的 水平，临床试验和癌症基因组学教育计划（CTC-GEP），该计划涉及确定性 非裔美国人（AA）和拉丁裔参与临床试验和癌症基因组学研究。 CTC-GEP是 通过少数群体参与临床试验（IMPACT）计划的信息，这是一个有效的临床试验 在阿拉巴马大学伯明翰O'Neal综合癌症实施的导航计划 中心。我们将基于该程序的发现，并将患者导航模型的应用扩展到 参与临床试验和基因组癌症研究。外行社区导航员专业人士的干部 将接受培训并用作临床试验导航员（CCN），以提供两种独特类型的工具包 基于证据的研究参与的教育资源（低技术）和文化量身定制的教育 以及通过移动平板技术技术（高科技）的多个媒体内容。 CCN将提供这些工具包，并 为有兴趣参与农村和城市癌症研究的参与者提供后勤支持 社区卫生和学术研究中心伙伴关系集水区。 CTC-GEP将 还涉及与参与有关 研究，例如隐私，信任和安全。基于逻辑模型的评估计划将在整个过程中应用 项目。结果指标将通过调查进行评估。 CTC的结果 GEP包括a）参与研究，b）有关研究的认识和知识的意图，c） 基因组研究和临床试验注册。此外，具有联合临床和生物医学研究 咨询圆桌会议（JCAR）指导，临床社区导航和教育计划将导致增加 意识，机会和参与基因组研究和临床试验的多样性人群 AAS和Latinx。旨在促进研究而不是进行研究的核心的理由是确定 促进AA和拉丁人种群研究的有效策略。那，活动 该提案中概述的综合策略是促进癌症的策略的一致 为外展核心列出了卫生平等（CPACHE）RFA。